Personalized Metabolic Nutrition for Sepsis

(PMNS Trial)

JA
RA
Overseen ByRajesh Aneja, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Children with sepsis, a condition in which infection causes organ dysfunction will be enrolled with parental permission in this study. Nutrition will be given according to their individual metabolic profiles until normalization of metabolism. Metabolism is the way that children process food to meet our body's needs, based on metabolic testing the children may need more or less carbohydrates, more or less fats or more or less protein. The investigators will measure whether normalization of metabolism with this personalized nutrition leads to resolution of organ dysfunction.

Who Is on the Research Team?

JA

Joseph A Carcillo, MD

Principal Investigator

Children's Hospital Department of Critical Care Medicine

CH

Christopher Horvat, MD

Principal Investigator

Children's Hospital of Pittsburgh, Department of Critical Care Medicine

Are You a Good Fit for This Trial?

This trial is for children with sepsis (a serious infection causing organ problems) whose parents give permission. Children are included if they have sepsis and need special nutrition based on their metabolism.

Inclusion Criteria

I have sepsis and my organs are failing.
I am older than 30 days and younger than 18 years.

Exclusion Criteria

Limitation of life-sustaining treatments
Expectation of death in 48 hours as deemed by the clinical PICU attending
I have chosen not to receive aggressive or life-prolonging treatments in the PICU.

What Are the Treatments Tested in This Trial?

Interventions

  • Low carbohydrate ketogenic formula
  • Low leucine, isoleucine formula
  • Medium chain triglyceride oil enriched formula
  • Standard nutrition

Trial Overview

The study compares different personalized nutrition formulas: one high in certain fats, one standard, one low in specific proteins, and one low-carb/ketogenic. Nutrition is tailored to each child's metabolic needs until their metabolism normalizes.

How Is the Trial Designed?

4

Treatment groups

Active Control

Placebo Group

Group I: Peds Sep B: Dysregulated Branched Chain Amino Acid Metabolism: Low leucine, isoleucine formulaActive Control1 Intervention
Group II: Peds Sep C: Dysregulated fat metabolism: Medium Chain Triglyceride Supplemented FormulaActive Control1 Intervention
Group III: Peds Sep D: Dysregulated carbohydrate metabolism: Low carbohydrate ketogenic formulaActive Control1 Intervention
Group IV: Peds Sep A: normal metabolism, standard nutritionPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Institute of General Medical Sciences (NIGMS)

Collaborator

Trials
315
Recruited
251,000+